أرسل هذا في رسالة قصيرة: Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments

  ______   __   __    _____     _____     _  _   
 /_   _//  \ \\/ //  / ____||  |  ___||  | \| || 
   | ||     \ ` //  / //---`'  | ||__    |  ' || 
  _| ||      | ||   \ \\___    | ||__    | .  || 
 /__//       |_||    \_____||  |_____||  |_|\_|| 
 `--`        `-`'     `----`   `-----`   `-` -`